Have a personal or library account? Click to login
Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy Cover

Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy

Forum of Clinical Oncology
Volume 13 (2022): Issue 3 (December 2022)
By: A. Koulouris,  C. Tsagkaris and  G. Mountzios  
Open Access
|Oct 2023

Figures & Tables

Figure 1:

Spatial and temporal aspects of intratumoral heterogeneity. The progression of the disease in the course of time culminates in cancer cells’ variation within and among primary and metastatic NSCLC.
Spatial and temporal aspects of intratumoral heterogeneity. The progression of the disease in the course of time culminates in cancer cells’ variation within and among primary and metastatic NSCLC.

Figure 2:

Schematic representation of intratumoral heterogeneity mechanisms and levels.
Schematic representation of intratumoral heterogeneity mechanisms and levels.
DOI: https://doi.org/10.2478/fco-2023-0005 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 3 - 14
Submitted on: Jun 20, 2023
Accepted on: Jul 25, 2023
Published on: Oct 12, 2023
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Nonsmall-cell lung cancer,
NSCLC,
heterogeneity,
immunotherapy,
targeted treatment
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2023 A. Koulouris, C. Tsagkaris, G. Mountzios, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 13 (2022): Issue 3 (December 2022)Next article